MoneyWorks4Me

Sakar Healthcare - Quaterly Results

24 Oct 2026 Evaluate
The turnover for the September 2026 quarter moved up 51.87% to Rs. 874.16 millions as compared to Rs. 575.60 millions during the year-ago period.Net Profit witnessed a 149.05% growth almost the double from Rs. 45.40 millions to Rs. 113.07  millions  of same quarter last year.Operating profit surged to 246.26 millions from the corresponding previous quarter of 125.69 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202609 202509 % Var 202609 202509 % Var 202603 202503 % Var
Sales 874.16 575.60 51.87 1603.88 1102.96 45.42 2517.36 1775.85 41.76
Other Income 2.81 12.15 -76.87 18.25 16.09 13.42 22.87 13.13 74.18
PBIDT 246.26 125.69 95.93 474.19 256.69 84.73 711.76 509.96 39.57
Interest 20.04 15.27 31.24 36.74 36.70 0.11 78.56 85.35 -7.96
PBDT 226.22 110.42 104.87 437.45 219.99 98.85 633.20 424.10 49.30
Depreciation 66.02 56.84 16.15 131.44 112.56 16.77 235.64 208.82 12.84
PBT 160.20 53.58 198.99 306.01 107.43 184.85 397.56 215.28 84.67
TAX 47.13 8.18 476.16 90.09 15.32 488.05 92.71 40.25 130.34
Deferred Tax 7.26 8.18 -11.25 10.88 15.32 -28.98 30.41 40.25 -24.45
PAT 113.07 45.40 149.05 215.92 92.11 134.42 304.85 175.03 74.17
Equity 222.50 222.50 0.00 222.50 222.50 0.00 222.50 219.50 1.37
PBIDTM(%) 28.17 21.84 29.01 29.57 23.27 27.04 28.27 28.72 -1.54
Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1303.00
Cipla 1353.00
Lupin 1950.00
Zydus Lifesciences 1158.10
View more..